| Pubmed ID |
Author |
Year |
Title |
|
26910747
|
Gursoy AY
|
2016
|
Is cystatin C level altered in women with polycystic ovary syndrome?
|
|
26911305
|
Yilmaz N
|
2016
|
Follicular fluid total antioxidant capacity levels in PCOS.
|
|
26913233
|
Mokhtar S
|
2015
|
ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial.
|
|
26913880
|
Sabbadin C
|
2016
|
The story of spironolactones from 1957 to now: from sodium balance to inflammation.
|
|
26913980
|
Calan M
|
2016
|
A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome.
|
|
26914110
|
Russo V
|
2016
|
Electrocardiographic indexes of arrhythmic risk in polycystic ovary syndrome.
|
|
26914398
|
Qi X
|
2016
|
The role of anti-M?llerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
|
|
26915924
|
Elizondo-Montemayor L
|
2017
|
Gynecologic and Obstetric Consequences of Obesity in Adolescent Girls.
|
|
26919524
|
Rahaman SN
|
2016
|
Cloning, expression, purification, crystallization and X-ray crystallographic analysis of recombinant human C1ORF123 protein.
|
|
26921577
|
Iwasa T
|
2015
|
The advancement of the onset of vaginal opening in female rats subjected to chronic testosterone treatment occurs independently of hypothalamic Kiss1 and RFRP expression.
|
|
26921624
|
Kim JY
|
2016
|
Distinguishing characteristics of metabolically healthy versus metabolically unhealthy obese adolescent girls with polycystic ovary syndrome.
|
|
26922384
|
Nahuis MJ
|
2016
|
Does the postcoital test predict pregnancy in WHO II anovulatory women? A prospective cohort study.
|
|
26924153
|
Moran LJ
|
2016
|
Erratum to: Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome.
|
|
26924636
|
Kollmann M
|
2016
|
Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis.
|
|
26927948
|
Paul C
|
2016
|
Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives.
|
|
26932210
|
Wang S
|
2016
|
[Effects of compound malt pills on expressions of ER? and ER? in ovaries of rats with letrozole-induced polycystic ovarian syndrome].
|
|
26935780
|
Ding Y
|
2016
|
Point mutation in mitochondrial tRNA gene is associated with polycystic ovary syndrome and insulin resistance.
|
|
26938199
|
Tian Y
|
2016
|
Variants in FSHB Are Associated With Polycystic Ovary Syndrome and Luteinizing Hormone Level in Han Chinese Women.
|
|
26941198
|
Guoqing Z
|
2016
|
Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome.
|
|
26941806
|
Amjadi F
|
2015
|
Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control study.
|
|
26943610
|
Nandi A
|
2016
|
Is there a role for vitamin D in human reproduction?
|
|
26944460
|
Worsley R
|
2016
|
Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens--Findings from the Fourth International Consultation on Sexual Medicine.
|
|
26945402
|
Wang Y
|
2016
|
Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
|
|
26948535
|
Goulis DG
|
2016
|
Presence of type 1 diabetes in women with polycystic ovary syndrome: Does it have any impact on anti-M?llerian hormone concentrations?
|
|
26951881
|
Nehir Aytan A
|
2016
|
Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
|
|
26952035
|
Gaspar RS
|
2016
|
Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats.
|
|
26952754
|
Cadagan D
|
2016
|
Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome.
|
|
26952756
|
Pandey V
|
2016
|
Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat.
|
|
26952782
|
Marsh CA
|
2016
|
Working memory in women with polycystic ovary syndrome.
|
|
26953707
|
Ciresi A
|
2016
|
Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency.
|
|
26955991
|
Laz?rov? I
|
2015
|
[Diagnostics of polycystic ovary syndrome].
|
|
26956932
|
de Graaff EC
|
2017
|
Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population.
|
|
26960762
|
Thomson RL
|
2016
|
Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
|
|
26961579
|
?ebkowska A
|
2016
|
Serum anti-M?llerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
|
|
26964728
|
Pasquali R
|
2016
|
Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
|
|
26965431
|
Hvidman HW
|
2016
|
Infertile women below the age of 40 have similar anti-M?llerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
|
|
26967765
|
Gul OO
|
2015
|
Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
|
|
26968296
|
Kalra S
|
2016
|
Endocrine and metabolic effects of Glucagon like peptide 1 receptor agonists (GLP1RA).
|
|
26968928
|
Ramezanali F
|
2016
|
Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-M?llerian hormone.
|
|
26969461
|
Kume T
|
2016
|
A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
|
|
26972165
|
De Sousa SM Dr
|
2016
|
Metabolic syndrome, diet and exercise.
|
|
26975253
|
Kokosar M
|
2016
|
Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.
|
|
26976018
|
Krawiec P
|
2016
|
Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.
|
|
26977831
|
Braun MM
|
2016
|
Diagnosis and Management of Endometrial Cancer.
|
|
26979020
|
Nicolino M
|
2015
|
[WHAT IS THE RISK FOR CHILDHOOD OBESITY?].
|
|
26979943
|
Szczuko M
|
2016
|
Effect of IGF-I and TNF-? on intensification of steroid pathways in women with PCOS phenotypes are not identical. Enhancement of progesterone pathway in women with PCOS increases the concentration of TNF-?.
|
|
26980102
|
Salehabadi M
|
2016
|
Association of G22A and A4223C ADA1 gene polymorphisms and ADA activity with PCOS.
|
|
26980590
|
?ak?ro?lu Y
|
2016
|
The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.
|
|
26983014
|
Carlus SJ
|
2016
|
Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis.
|
|
26983336
|
Gundelach T
|
2016
|
[Metformin for the treatment of polycystic ovary syndrome].
|
|
26984837
|
Wu Y
|
2016
|
Acupuncture for treating polycystic ovary syndrome: guidance for future randomized controlled trials.
|
|
26985336
|
Zahiri Z
|
2016
|
Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.
|
|
26985764
|
Oru? AS
|
2016
|
A Study of Serum Soluble CD 163 Levels in Women with Polycystic Ovary Syndrome.
|
|
26989412
|
Kyaw Tun T
|
2016
|
Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome.
|
|
26990942
|
Torchen LC
|
2016
|
Evidence for Increased 5?-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.
|
|
26993517
|
Mikaeili S
|
2016
|
Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome.
|
|
26995146
|
Nambiar V
|
2016
|
Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
|
|
26995881
|
Sirota I
|
2016
|
Insulin Resistance and ?-cell Function Calculated by Homeostasis Model Assessment in Lean, Overweight, and Obese Women with Polycystic Ovary Syndrome.
|
|
26995885
|
Polat SB
|
2016
|
Thyroid Disorders in Young Females with Polycystic Ovary Syndrome and Correlation of Thyroid Volume with Certain Hormonal Parameters.
|
|
26995937
|
Brazert M
|
2015
|
Insulin-like growth factor-1 isoforms in human ovary. Preliminary report on the expression of the IGF-1 gene in PCOS patients and healthy controls.
|
|
26997468
|
Cappy H
|
2016
|
Low vitamin D3 and high anti-M?llerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
|
|
26997601
|
Shahrami SH
|
2016
|
The Relation between Diverse Phenotypes of PCOS with Clinical Manifestations, Anthropometric Indices and Metabolic Characteristics.
|
|
26997714
|
Bubna AK
|
2016
|
Metformin - For the dermatologist.
|
|
26999875
|
Klein J
|
2015
|
Polycystic Ovarian Syndrome.
|
|
27000076
|
Verrotti A
|
2016
|
Valproic Acid Metabolism and its Consequences on Sexual Functions.
|
|
27001999
|
Huang X
|
2016
|
Identification of altered microRNAs and mRNAs in the cumulus cells of PCOS patients: miRNA-509-3p promotes oestradiol secretion by targeting MAP3K8.
|
|
27002301
|
Conti R
|
2016
|
Polycystic ovary syndrome and vitiligo: simple association or tight connection?
|
|
27003383
|
Emekci Ozay O
|
2016
|
Role of kisspeptin in polycystic ovary syndrome (PCOS).
|
|
27007571
|
Victor VM
|
2016
|
Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase.
|
|
27008892
|
Mumm H
|
2016
|
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
|
|
27011370
|
Wang B
|
2016
|
Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome.
|
|
27014589
|
Agarwal S
|
2016
|
Liver X Receptor-? polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo.
|
|
27018331
|
Wang CC
|
2016
|
The clinical and biochemical characteristics associated with insulin resistance in non-obese young women<sup/>.
|
|
27018756
|
Fruzzetti F
|
2016
|
Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
|
|
27018935
|
Fields EL
|
2016
|
Treatment Considerations for the Cardiometabolic Signs of Polycystic Ovary Syndrome: A Review of the Literature Since the 2013 Endocrine Society Clinical Practice Guidelines.
|
|
27025792
|
Forouhi N
|
2016
|
Serum C1q and tumor necrosis factor (TNF)-related protein 9 in women with Polycystic Ovary Syndrome.
|
|
27026772
|
Suvarna Y
|
2016
|
Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome.
|
|
27028341
|
Gupta A
|
2016
|
Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome.
|
|
27032432
|
Tolstrup J
|
2016
|
[Complications in pregnant women with polycystic ovary syndrome].
|
|
27034186
|
Glintborg D
|
2016
|
Endocrine and metabolic characteristics in polycystic ovary syndrome.
|
|
27034774
|
Ouyang P
|
2016
|
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists.
|
|
27035648
|
Liu HY
|
2016
|
Transcription factor?microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.
|
|
27039650
|
Davies N
|
2016
|
PCOS: Polycystic Ovarian Syndrome.
|
|
27039809
|
Yousuf SD
|
2016
|
The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India.
|
|
27042970
|
Torchen LC
|
2016
|
Increased antim?llerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome.
|
|
27046189
|
Li L
|
2016
|
The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome.
|
|
27046958
|
Allahbadia GN
|
2016
|
Primum Non Nocere.
|
|
27047563
|
Riahinejad S
|
2015
|
Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome.
|
|
27049276
|
Yang B
|
2016
|
Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome.
|
|
27050252
|
Razavi M
|
2016
|
The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
|
|
27052492
|
Behboudi-Gandevani S
|
2016
|
Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies.
|
|
27052493
|
Hrovat A
|
2016
|
SORCS1 polymorphism and insulin secretion in obese women with polycystic ovary syndrome.
|
|
27053365
|
Lu C
|
2016
|
Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep.
|
|
27056885
|
Xu J
|
2016
|
Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.
|
|
27060006
|
Zhao S
|
2016
|
Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism.
|
|
27060174
|
Toftager M
|
2016
|
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
|
|
27061312
|
Luotola K
|
2016
|
IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome.
|
|
27061597
|
Turkmen S
|
2016
|
The author's reply: Blood allopregnanolone levels in women with polycystic ovary syndrome.
|
|
27061682
|
Kanamarlapudi V
|
2016
|
Luteinizing hormone/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active.
|
|
27061737
|
Saito K
|
2016
|
Blood allopregnanolone levels in women with polycystic ovary syndrome.
|